Edwards Lifesciences Corp — Director's Dealing 2021

Feb 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-02-11

Reporting Person: WANG HUIMIN (CVP, Japan & Intercontinental)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-11	Common Stock	M	11661.0000	$13.9800	Acquired	104958.1404	Direct
2021-02-11	Common Stock	S	11745.0000	$86.8100	Disposed	93213.1404	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-11	Employee Stock Option (Right to Acquire)	$13.9800	M	11661.0000	Disposed	2021-05-07	Common Stock (11661.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.